Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,971.00
Bid: 1,971.00
Ask: 1,972.00
Change: -29.00 (-1.45%)
Spread: 1.00 (0.051%)
Open: 2,008.00
High: 2,012.00
Low: 1,958.00
Prev. Close: 2,000.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hikma injects new life into annual profit, remains optimistic about 2015

Wed, 11th Mar 2015 08:16

Strong performances in Hikma Pharmaceuticals' injectable drug business drove the company's annual pre-tax higher by over 20%, though a warning about the impact of the US dollar on 2015 revenues was perhaps behind an initial fall in the shares.The Jordanian drugmaker reported a 21% year-on-year increase in pre-tax profit to $362m (£240.3m), while revenue rose 9% to $1.49bn, exceeding management's guidance of revenue growth of around 7% for the year.A 51% increase in revenue in the US, drove revenue in the group's injectable drug business higher by 33% to $713m, having raised its full-year revenue growth forecast for the unit to 25% late in 2014 , with adjusted operating margins of above 35%.The injectable drug business accounted for 48% of total sales at the FTSE 250 group, a 9% increase year-on-year.Hikma, which is set to join the FTSE 100 index later in March, reported adjusted operating margin of 37.2% and said that it was confident of delivering a similar performance in 2015, forecasting adjusted operating margins to be around 35%.But it cautioned that the storming US dollar looked like it could dent 2015 revenues by around 3%."Hikma should now be in a better position to weather the eventual resolution of current drug shortages and continue to grow the sterile injectables business albeit at a slower pace near term," analysts at Shore Markets said in a note on Wednesday.However, the broker warned that a stronger-than-expected performance in 2014 made it for a tougher comparator in 2015.Hikma shares were down 2.76% to 2,250.00 at 08:41 on Wednesday.
More News
12 Apr 2023 07:52

LONDON BRIEFING: Anglo American's De Beers shines; Unite bookings up

(Alliance News) - Stocks in London were called flat on Wednesday, with the focus for the day on a US inflation reading in the afternoon, before the release of central bank meeting minutes later.

Read more
12 Apr 2023 07:18

Hikma appoints Riad Mishlawi as CEO

(Sharecast News) - Hikma Pharmaceuticals said Riad Mishlawi, president of the group's injectables business, has been appointed chief executive Officer, effective from September 1.

Read more
6 Apr 2023 09:20

LONDON BROKER RATINGS: Goldman raises Spirent to 'neutral' from 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
16 Mar 2023 15:50

UK dividends calendar - next 7 days

Friday 17 March 
JPMorgan Claverhouse Investment Trust PLCdividend payment date
Knights Group Holdings PLCdividend payment date
NCC Group PLCdividend payment date
Pershing Square Holdings Ltddividend payment date
Ruffer Investment Co Ltddividend payment date
Witan Investment Trust PLCdividend payment date
Monday 20 March 
Aquila Energy Efficiency Trust PLCdividend payment date
Essentra PLCspecial ex-dividend payment date  
Shaftesbury Capital PLCdividend payment date
Tuesday 21 March 
abrdn Asia Focus PLCdividend payment date
Impax Asset Management Group PLCdividend payment date
Unilever PLCdividend payment date
Wednesday 22 March 
abrdn Equity Income Trust PLCdividend payment date
Thursday 23 March 
BlackRock Energy & Resources Income Trust PLCex-dividend payment date
British American Tobacco PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
Close Brothers Group PLCex-dividend payment date
CLS Holdings PLCex-dividend payment date
Craneware PLCex-dividend payment date
Diverse Income Trust PLCex-dividend payment date
Glanbia PLCex-dividend payment date
HgCapital Trust PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
Hipgnosis Songs Fund Ltdex-dividend payment date
Jersey Electricity PLCdividend payment date
Nichols PLCex-dividend payment date
Palace Capital PLCex-dividend payment date
Pearson PLCex-dividend payment date
Prudential PLCex-dividend payment date
Schroders PLCex-dividend payment date
Securities Trust of Scotland PLCex-dividend payment date
Volution Group PLCex-dividend payment date
XP Power Ltdex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
13 Mar 2023 09:40

LONDON BROKER RATINGS: JPMorgan cuts BAT; raises Bunzl

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
9 Mar 2023 09:15

LONDON BROKER RATINGS: Liberum cuts National Express to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Mar 2023 09:48

LONDON BROKER RATINGS: DB cuts Reckitt; Jefferies likes Tesco

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.